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Abstract
Immunomagnetic separation (IMS) can selectively isolate and concentrateMycobacterium bovis cells from lymph node tissue
to facilitate subsequent detection by PCR (IMS-PCR) or culture (IMS-MGIT). This study describes application of these novel
IMS-based methods to test for M. bovis in a survey of 280 bovine lymph nodes (206 visibly lesioned (VL), 74 non-visibly
lesioned (NVL)) collected at slaughter as part of the Northern Ireland bovine TB eradication programme. Their performance
was evaluated relative to culture. Overall, 174 (62.1%) lymph node samples tested positive by culture, 162 (57.8%) by IMS-
PCR (targeting IS6110), and 191 (68.2%) by IMS-MGIT culture. Twelve (6.9%) of the 174 culture positive lymph node samples
were not detected by either of the IMS-based methods. However, an additional 79M. bovis positive lymph node samples (27
(13.1%) VL and 52 (70.3%) NVL) were detected by the IMS-based methods and not by culture. When low numbers of viable
M. bovis are present in lymph nodes (e.g. in NVLs of skin test reactor cattle) decontamination prior to culture may adversely
affect viability, leading to false negative culture results. In contrast, IMS specifically captures whole M. bovis cells (live, dead
or potentially dormant) which are not subject to any deleterious treatment before detection by PCR or MGIT culture. During
this study only 2.7% of NVL lymph nodes tested culture positive, whereas 70.3% of the same samples tested M. bovis
positive by the IMS-based tests. Results clearly demonstrate that not only are the IMS-based methods more rapid but they
have greater detection sensitivity than the culture approach currently used for the detection of M. bovis infection in cattle.
Adoption of the IMS-based methods for lymph node testing would have the potential to improve M. bovis detection in
clinical samples.
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Introduction
Bovine tuberculosis (bTB) is an infectious disease of cattle
caused by the bacterium Mycobacterium bovis, a member of the
Mycobacterium tuberculosis (MTB) complex. It is a significant animal
health issue in countries including the United Kingdom and
Ireland where its incidence has been broadly rising for 25 years.
This affects cattle based agriculture impacting on profitability and
trade. M. bovis has a wide host range [1] making eradication
difficult and resulting in some animals becoming wildlife reservoirs
of the disease [2,3]. The current primary method of screening live
cattle in the UK for bTB is the single intradermal comparative
cervical tuberculin (SICCT) test, carried out using purified protein
derivative (PPD) from M. bovis and Mycobacterium avium, according
to Annex B of European Directive 63/432/EEC (as amended).
Under EU legislation, all skin test reactors are mandatorily
slaughtered and tissues may be removed for disease confirmation
by histopathology or mycobacterial culture. Culture of M. bovis is
the current ‘gold standard’ for confirmation of disease diagnosis
[4]. However, it can be problematic for a number of reasons which
include: i) the precise selection of infected tissue for culture; ii) the
paucibacillary nature of M. bovis in the tissues selected; iii) harsh
decontamination procedures that are a prerequisite to culture
which can significantly reduce M. bovis viability; and iv) the slow-
growing nature of M. bovis resulting in an eight week time lag for
confirmation of its presence or absence in clinical samples. The
outcome is that mycobacterial culture is both time consuming and
expensive, insensitive due to ii) and iii), and delays disease
confirmation.
A major difficulty with diagnosing bTB is that there is no
simple, sensitive test to determine when a bacterium is viable,
other than by using culture methods. Low culture positive rates for
skin test NVL reactors might be due to low numbers of bacteria in
tissues and to the detrimental effects of decontamination with
potentially low recovery of bacilli. In view of the low culture
positive rate for M. bovis from reactors with no visible lesions
(NVL), there is the possibility of a gross underestimation in the
proportion of test reactor cattle with confirmed TB infection. This
could, in turn, affect the way in which TB breakdowns are
managed, since failure to detect visible lesions and to recover M.
bovis may lead to a less stringent follow-up TB herd testing regime
to regain officially TB free status. Tissues from test reactor animals
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can contain visible lesions (VL) or there may be no visible lesions
(NVL) evident. In the United Kingdom, under EU legislation, all
cattle routinely slaughtered for human consumption and not
removed as SICTT reactors are routinely checked post mortem
for the presence of tuberculous lesions. When suspect TB lesions
are found in non-reactor animals during meat inspection at
routine slaughter (designated ‘‘lesions at routine slaughter’’ in
Northern Ireland or ‘‘slaughterhouse case’’ in Great Britain
context) a sample of the affected tissue is also sent for TB culture.
The protocol used for the selection of tissue samples for
mycobacterial culture in the UK differs depending on, inter alia,
the results of the herd level SICTT test, the history of the herd and
animal, and the presence or absence of visible TB lesions at
slaughter, i.e. not all reactors will have the same tissue samples
examined. Indeed, many have no further sampling e.g. when
disease previously confirmed in the herd. When lesions are present
a small portion of infected tissue (,1 g) is prepared for culture (as
well as histopathology), however, as confirmation rates of M. bovis
infection in NVL samples by conventional culture are low, a larger
sample of lymph node tissue (#10 g) is cultured from NVL reactor
animals.
The development of a rapid, more sensitive and specific
screening test for M. bovis would allow veterinary authorities to
quickly confirm bTB infection (and more often) in suspect herds.
We recently reported the production of novel monoclonal
antibodies and phage-display derived peptide ligands to M. bovis
surface antigens and their evaluation for immunomagnetic
separation (IMS) [5]. Tosylactivated Dynabeads dually coated
with an IgM monoclonal antibody and a biotinylated 12– mer
peptide binder achieved maximal capture of M. bovis from broth
cultures and spiked lymph node samples. Preliminary studies
determined that these binders were both specific and sensitive
when applied to pure broth cultures of a range of commonly
locally isolated spoligotypes of M. bovis, and that there was no
significant cross-reactivity with any of the environmental Mycobac-
terium spp. tested or M. bovis BCG. In the UK, the TB culture
method involves chemical decontamination of lymph node
samples with oxalic acid, which is known to have an adverse
effect on the viability of mycobacteria, in addition to the desired
killing effect on non-mycobacterial contaminants [6]. IMS could
potentially circumvent the need for chemical decontamination, by
selectively capturing M. bovis cells and separating them from other
bacteria in the samples, thereby retaining viability of M. bovis cells.
Furthermore, IMS introduces specificity for M. bovis prior to
IS6110 PCR and also removes sample matrix constituents that
may inhibit the Taq enzyme used in the PCR reaction. Our
original intention was to employ IMS in conjunction with a phage
amplification assay to achieve rapid detection (within 48 h) of
viable M. bovis cells in lymph node tissue, as has been reported
previously for M. avium subsp. paratuberculosis [7,8]. However,
preliminary testing of naturally infected lymph nodes, prior to
commencement of the larger scale testing reported here, yielded
some unexpected results which meant that our proposed testing
approach using an IMS-phage assay was not feasible. Therefore,
the aim of the present study was to evaluate the performance of the
recently developed and optimised IMS method (5), used in
combination with IS6110 touchdown PCR and MGIT liquid
culture, to detect M. bovis during a survey of naturally infected
Figure 1. Interrelationships between Culture, IMS-PCR and IMS-MGIT PCR positive results. (A) visibly lesioned lymph nodes from reactor
cattle, (B) non-visibly lesioned lymph nodes from reactor cattle, (C) visibly lesioned lymph nodes from non-reactor cattle detected at routine
slaughter, and (D) all lymph node samples, irrespective of type.
doi:10.1371/journal.pone.0058374.g001
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bovine lymph node tissues. IS6110 is a multiple copy insertion
element originally thought to be exclusively found in the genome
of MTB complex organisms [9,10,11]. However, it has recently
been found in the genome of Mycobacterium smegmatis [12] and
another environmental Mycobacterium sp. [13]. In light of the fact
that the optimised IMS method introduces specificity for M. bovis,
the fact that IS6110 may be detected from other mycobacterial
species is immaterial in relation to IMS-PCR results. Results
obtained with the IMS-based methods were compared with results
obtained with the reference mycobacterial culture and direct PCR
methods. The IMS-based methods were demonstrated to have
greaterM. bovis detection capability, particularly when testing non-
visibly lesioned lymph nodes from reactor cattle.
Materials and Methods
Samples tested
A selection of 280 bovine tissue samples submitted routinely to
the Statutory TB Laboratory, Agri-Food and Biosciences Institute
for Northern Ireland (AFBI), Stormont, Belfast, were tested during
this study; 240 were from skin test reactor animals (74 NVL and
166 VL) and 40 were from non-reactor animals with lesions
detected at routine slaughter. Permission was given by Department
of Agriculture and Rural Development (DARD) for Northern
Ireland to test samples submitted under its TB eradication scheme
during this study. We had no control over how the tissue samples
were taken in the abattoirs and hence cannot exclude the
possibility of cross-contamination between samples at point of
collection.
Tissue samples from both VL and NVL samples were initially
cut into cubes (5 mm65 mm) and divided into two visually similar
portions in terms of sample size, lesion type and distribution. One
portion was processed through the mycobacterial culture pro-
cedure and the second portion was frozen at 220uC until
prepared for IMS. Samples of NVL only or VL only were
processed in separate batches to prevent cross-contamination
between potentially heavily infected VL samples and lightly or
non-infected NVL samples. Samples were also prepared in-
dividually to prevent cross-contamination. All work was carried
out in a Class I biological safety cabinet under Containment Level
3 laboratory conditions for health and safety reasons.
Mycobacterial culture
NVL tissue samples. Cubed lymph node sample (ap-
prox.10 g) was ground with a small amount of sterile sand using
a mortar and pestle before the addition of 12 ml 5% oxalic acid.
The sample was mixed again and the liquid content transferred to
a centrifuge tube, discarding the remaining solid material from the
mortar. The sample was transferred to a rotary mixer and mixed
for 15 min at 37uC, followed by centrifugation at 1,6206g for
15 min. The supernatant was discarded and the sediment washed
twice in sterile phosphate buffered saline (PBS). Two Lowenstein-
Jensen slopes containing pyruvate and two Stonebrink slopes
containing pyruvate (Media for Mycobacteria, Cardiff, UK) were
inoculated with the resulting sediment using a sterile swab and
incubated at 37uC for a minimum of 8 weeks. The remaining
sediment (500 ml) in sterile PBS was vortexed to form a liquefied
emulsion and inoculated into MGIT (Mycobacterium growth
indicator tube) culture medium supplemented with MGIT OADC
and MGIT PANTA antibiotic cocktail (both Becton Dickinson) as
per the manufacturer’s instructions. Each tube was scanned into
the Bactec MGIT 960 machine and incubated for up to 8 weeks at
37uC or until growth was detected.
VL tissue samples. Approximately 1 g of cubed VL tissue
was deposited into a ribolyser tube and 600 ml 5% oxalic acid
added. The tissue was homogenised in a Hybaid Ribolyser for
2630 second cycles at 6.5 m/s, mixed on a rotary mixer for
15 min at 37uC, and then centrifuged at 11,3006g for 5 min. The
supernatant was discarded and the sediment neutralised and
resuspended by adding 400 ml PBS. Two Lowenstein-Jensen
slopes containing pyruvate and two Stonebrink slopes containing
pyruvate were inoculated and incubated at 37uC for a minimum of
8 weeks.
‘Lesions at routine slaughter’ tissue samples. The same
procedure as for VL samples was applied except that the pellet was
neutralised and resuspended using 700 ml PBS, 500 ml of which
was inoculated into a MGIT tube and the remainder onto the
solid media as above.
Tissue preparation for Direct PCR and IMS
Cubed lymph node tissue (3 g) was ground with a small amount
of sand and 4.5 ml PBS in a sterile mortar. The liquid portion was
transferred to a centrifuge tube and the remaining solid material
was discarded from the mortar. The sample was centrifuged at
3006g for 3 min to sediment sand and tissue particulates. A 1:10
dilution of the clarified tissue supernatant was made in sterile PBS,
100 ml of which was used directly for IS6110 touchdown PCR and
1 ml for IMS.
Direct IS6110 Touchdown PCR. Diluted tissue homogenate
(100 ml) was heat-inactivated in screw-capped microcentrifuge
tubes by boiling for 25 min at 100uC in a water bath. Samples
were centrifuged at 11,3006g for 1 min. DNA was extracted and
concentrated from heated samples using Zymoclean DNA Clean
and ConcentratorTM-5 kit (Zymo Research Corporation, Irvine,
California, USA) as per kit instructions. DNA was eluted from the
column in 10 ml Tris-EDTA buffer (TE, pH 8). Each PCR
reaction consisted of 45 ml Platinum Blue PCR SuperMix (Life
Technologies) plus 1 mM of each primer (INS1 59-cgt gag ggc atc
gag gtg gc-39 and INS2 59-gcg tag gcg tcg gtg aca aa-39) [13],
2 mM MgCl2 and 5 ml of template DNA. Touch-down PCR
amplification was performed on a Techne TC-512 thermal cycler
according to the protocol used by Zuma´rraga et al. [14], with an
initial denaturation step of 96uC for 3 min, followed by 8 cycles of
denaturation at 96uC for 1 min, annealing temperature starting at
72uC for 1 min and decreasing by 1uC/cycle, and 72uC for 1 min
for extension. This step was followed by 30 cycles of 96uC for
Figure 2. Interrelationships between Culture, Direct PCR and
IMS-PCR positive results for all 280 lymph node samples,
irrespective of type.
doi:10.1371/journal.pone.0058374.g002
IMS-Based Methods for M. bovis Detection
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1 min, 65uC for 1 min, 72uC for 2 min, and a final extension at
72uC for 8 min before holding at 4uC. PCR products were
visualised by 2% agarose gel electrophoresis and ethidium
bromide staining and gels photographed using UVP gel acquisi-
tion software.
Automated IMS. Dually coated (Mab 11G3 and biotinylated
peptide EEA302) MyOne tosylactivated Dynabeads (10 ml), pre-
pared in-house according to the manufacturer’s instructions, were
added to the first well of BeadRetriever strip (Life Technologies),
1 ml of PBS-0.05% Tween 20 wash buffer to the next two wells,
and 300 ml PBS to the fourth well. The previously prepared 1:10
dilution (1 ml) of the clarified tissue supernatant was then added to
the first well of the BeadRetriever strip. The tube rack, containing
up to 15 samples, was transferred to the Dynal BeadRetriever (Life
Technologies) and IMS was performed using the pre-loaded
‘Environmental’ programme. This pre-set programme consists of
a 35 minute incubation period in well 1 of the bead retriever strip
with mixing at a medium speed throughout. The beads are then
captured and transferred to well 2 and washed for 1 min at
a medium speed. After a second transfer into well 3 the beads are
washed again for 1 min at medium speed. The final transfer is into
well 4 where the beads are released into 300 ml PBS using a 10 sec
high speed mix. The resuspended beads were then split into three
100 ml aliquots for: (1) M. bovis touchdown PCR (IMS-PCR); (2)
MGIT culture without decontamination (IMS-MGIT) and (3)
potential spoligotyping (IMS-spoligotyping).
IMS-PCR. DNA was extracted from M. bovis cells in 100 ml of
each bead suspension by heating in screw-cap microcentrifuge
tubes at 100uC for 25 min in a waterbath. After a brief
centrifugation, DNA was extracted and concentrated from each
sample and IS6110 Touchdown PCR performed as described
above for Direct PCR.
IMS-MGIT culture. 100 ml aliquot of each bead suspension
was inoculated directly into a MGIT tube supplemented with
MGIT OADC and MGIT PANTA as per the mycobacterial
culture procedure (described earlier) and incubated for up to
8 weeks at 37uC. Any IMS-MGIT cultures that indicated growth
positive on the MGIT system throughout the incubation period
were removed and examined for the presence of acid-fast bacteria
typical of M. bovis by Ziehl-Neelsen (ZN) staining. Additionally, all
IMS-MGIT cultures were subjected to ZN staining at the end of
the 8 week incubation period. When acid-fast bacteria were
observed a sub-sample of the culture was spoligotyped by the
method of Roring et al. [16]. If M. bovis typical spoligotype profiles
were obtained, cultures were considered M. bovis positive, and will
be referred to as IMS-MGIT (ZN) positive. Additionally, all IMS-
MGIT cultures at the end of the 8 week incubation period were
subjected to IS6110 touchdown PCR. Any of these cultures which
tested PCR positive were spoligotyped and considered M. bovis
positive if spoligotyping was successful. These IMS-MGIT results
will be referred to as IMS-MGIT (PCR) positive.
IMS-spoligotyping. The remaining 100 ml aliquot of bead
suspension was stored at 220uC until the IMS-PCR assay
indicated a positive result i.e. if there was any evidence of M.
bovis DNA being present, at which point a selection of IMS-PCR
positive samples were thawed, boiled at 100uC for 8 min and then
DNA subjected to spoligotyping using the method of Roring et al.
[15] which is routinely used at AFBI. In addition, separate trials
evaluating the outcome of spoligotyping applied to different
concentrations of M. bovis AF2122/97 were carried out to assess
the likelihood of obtaining a full spoligotype profile if low numbers
of M. bovis cells were present after IMS. Ten-fold dilutions of M.
bovis AF2122/97 (containing approx. 56106–10 CFU/ml) were
prepared in PBS, subjected to automated IMS (as described
above), and the beads resuspended in 300 ml PBS. A 100 ml
aliquot of each sample was boiled for 8 min and spoligotyped [15].
The other 200 ml was boiled for 25 min, DNA extracted and
concentrated using the Zymoclean kit, and DNA eluted in 10 ml
TE buffer before spoligotyping.
Statistical analysis of results
Test performance was assessed using McNemar’s Chi-Square
test (GenStat version 14.2) to analyse 262 contingency tables.
Survey results were also subjected to generalised linear mixed
model analysis (GLMM, Genstat version 14.2) to determine the
Table 1. Comparison of IMS-PCR and Direct PCR results for 280 lymph node samples –74 non-visibly lesioned (NVL) and 206 visibly
lesioned (VL).
Type of
sample (No.)
IMS-PCR+,
Direct PCR +
IMS-PCR +,
Direct PCR 2
IMS-PCR 2,
Direct PCR +
IMS-PCR 2,
Direct PCR 2 x2 (P value.a)
VL (206) 71 59 36 40 4.594 (0.032)
NVL (74) 18 14 17 25 0.000 (0.000)
All (280)b 89 73 53 65 3.150 (0.076)
aDetermined by McNemar’s Chi-Square test using Genstat version 14.2.
bIncludes 166 VL and 74 NVL samples from TB skin test reactor animals plus 40 VL samples from non-reactor animals detected at routine slaughter.
Data represent number of samples with each combination of test results.
doi:10.1371/journal.pone.0058374.t001
Table 2. Comparison of results for alternative detection
methods and culture (MGIT broth or Lowenstein-Jensen
slope).
Alternative method
and result Culture result x2 (P valuea)
Positive Negative
Direct PCR + 88 53 7.367 (0.007)
Direct PCR – 86 53
IMS-PCR + 109 53 1.025 (0.311)
IMS-PCR – 65 53
IMS-MGIT (ZN) + 59 4 101.681 (0.000)
IMS-MGIT (ZN) – 115 102
IMS-MGIT (PCR) + 139 51 2.616 (0.106)
IMS-MGIT (PCR) – 35 55
aDetermined by McNemar’s Chi-Square test using GenStat Release 14.2.
Results for all 280 lymph node samples are not broken down by lymph node
type.
doi:10.1371/journal.pone.0058374.t002
IMS-Based Methods for M. bovis Detection
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probability of a positive detection of M. bovis by each test and to
assess if the type of lymph node tested (VL versus NVL) influenced
the test outcome.
Results and Discussion
IMS-based methods (IMS-PCR and IMS-MGIT culture)
compared to mycobacterial culture and Direct PCR
A total of 280 lymph node tissue samples, comprised of 206 VL
samples (166 from skin test reactor animals and and 40 from non-
reactor animals with lesions at routine slaughter) and 74 NVL
samples, were subjected to culture, Direct PCR, IMS-PCR and
IMS-MGIT culture. IMS-PCR, Direct PCR and IMS-MGIT
culture were applied to aliquots of the same lymph node
homogenate, whereas culture had to be carried out on a separate
portion of the same lymph node because it involves initial
homogenisation in oxalic acid. Overall, only 27 (9.6%) of the 280
lymph node samples tested were negative for presence of M. bovis
by all tests applied. In total, 174 lymph node samples –2 (2.7%) of
74 NVL and 172 (83.5%) of 206 VL samples (151 (91.0%) of 166
VL reactors and 21 (52.5%) of 40 VL ‘at routine slaughter’ cases) –
tested M. bovis positive by the culture method. In the culture
system, lymph node culture is only considered positive for M. bovis
if typical acid-fast cords observed in MGIT cultures or suspect
colonies on Lowenstein-Jensen or Stonebrink slopes are sub-
sequently confirmed to be M. bovis by spoligotyping. Figure 1
illustrates the interrelationships between culture, IMS-PCR and
IMS-MGIT (PCR) results for lymph nodes from reactor animals
with VL (Fig. 1A), reactor animals with NVL (Fig. 1B), non-
reactor animals with VL at routine slaughter (Fig. 1C), and all
lymph node samples irrespective of type (Fig. 1D. Collectively, the
IMS-based methods (IMS-PCR and IMS-MGIT culture) detected
the presence of M. bovis in 162 (93%) of the 174 culture positive
samples, but also in an additional 79 (28.2%) lymph node samples
(52 NVL and 27 VL samples, comprising 13 from skin test reactor
animals and 14 from ‘lesions at routine slaughter’ cases). Hence,
the IMS-based methods achieved improved detection rates of M.
bovis in lymph node tissues, particularly with NVL samples from
reactor animals. The majority (112/162, 70%) of the IMS-PCR
positive results (result obtained within 48 h of testing) later
translated to an IMS-MGIT culture positive result (after 8 week
incubation period) confirming the presence of viable M. bovis cells
in these lymph node samples and not just detection of M. bovis
DNA. Essentially, the only difference between the IMS-PCR and
IMS-MGIT (PCR) results is due to the effect of an 8 week
incubation period on captured M. bovis cells, which should have
permitted resuscitation and replication. However, for 27 of the 78
lymph node samples (14 NVL and 13 VL samples) an initial
positive IMS-PCR result did not translate to either a culture or
IMS-MGIT (PCR) positive result. These may represent lymph
node samples containing M. bovis cells that were unable to
resuscitate during either culture or IMS-MGIT culture, or dead
M. bovis cells.
In the case of the NVL samples, the difference between results
of culture and IMS-based methods was particularly marked –54
(73%) of 74 NVL samples tested positive for M. bovis by IMS-PCR
or IMS-MGIT culture, whereas only 2 (2.7%) of 74 NVL samples
were recorded as culture positive. This is a particularly important
finding and if validated on a larger scale would make a significant
contribution to understanding non-visible lesion status, which has
confounded comprehension of the disease in cattle. NVL tissues
without laboratory disease confirmation are problematic at the
epidemiological level [16] since there is no disclosed seat of
infection to explain skin test positivity. Confirmation of exposure
to M. bovis through the presence of specific DNA sequences, or
viable M. bovis, detected by IMS-based methods would help to
explain immune recognition and recall in the absence of culture
positive status.
As reported above, an additional 79 lymph nodes were
indicated M. bovis positive by the IMS-based detection methods
(IMS-PCR and IMS-MGIT) than by culture. Amongst this
number were 30 IMS-MGIT culture positive lymph nodes
emanating from animals in 10 herds from which multiple animals
(between two and six animals per herd) had been tested. The
animals concerned were principally, but not exclusively, skin test
reactor animals presenting with no visible lesions at time of
slaughter. When the histories of the 10 herds were further
investigated, six of the herds were found to have had a recent
history of bTB infection and four were previously bTB free.
Therefore, the novel IMS-MGIT culture method was confirming
TB infection in these herds, when culture had not. However, it
must be acknowledged that interpretation of the enhanced
sensitivity of the IMS-based methods may be compromised by
the possibility that cross-contamination upon collection of tissue
samples from carcases at the abattoir may have occurred. This
possibility should be taken into account when interpreting IMS-
based method findings and results considered in the context of
prior herd and/or animal history.
Figure 3. Relative probabilities of M. bovis detection in (A)
visibly lesioned and (B) non-visibly lesioned lymph nodes by
culture and four alternative detection methods. Three of the
alternative methods employ IMS as first step.
doi:10.1371/journal.pone.0058374.g003
IMS-Based Methods for M. bovis Detection
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Comparison of Direct PCR and IMS-PCR test results with
culture results
Results of the two PCR detection methods are compared with
culture results in Figure 2. PCR bands of variable, but generally
low, intensity were observed after IMS-PCR and Direct PCR,
which suggested variable numbers of M. bovis in PCR positive VL
and NVL samples. This would be consistent with the variable
numbers ofM. bovis (486–2.546106 genome equivalents) estimated
to be present in infected lymph node samples by quantitative
IS1081 real-time PCR previously [17]. Together, the two IS6110
based PCR methods indicated the presence of MTB complex
DNA in 214 (76.4%) of the 280 lymph node samples tested. In
contrast, culture indicated the presence of viable M. bovis in 174
(62.1%) lymph node samples. Fifty-six (32.2%) of the 174 culture
positive samples also gave positive results by both IMS-PCR and
Direct PCR. Thirty-two (18.4%) lymph node samples (all VL)
tested culture positive for M. bovis but tested negative by either
IMS-PCR or Direct PCR, or both PCR methods. The remaining
86 (49.4%) culture positive samples also had an IMS-PCR or
a Direct PCR positive result. The 32 culture positive but PCR
negative results obtained may provide evidence of PCR inhibition,
due to the refractory nature of VL lymph nodes, which can be pus-
filled, caseated and calcified. Taylor et al. [17] have previously
shown that the discrepancy between sensitivity of detection found
with purified mycobacterial DNA and direct testing of field
samples was due to limited mycobacterial DNA recovery from
tissue homogenates rather than PCR inhibition. Further con-
siderations are that: (a) two separate portions of the same lymph
node sample were used for culture and PCR methods, whereas the
same lymph node homogenate was analysed by the two PCR
methods; (b) different amounts of lymph node tissue extract were
used in various test protocols; (c) the coated beads have been
shown to bind clumps of M. bovis cells and as the IMS samples
were split before analysis it is possible that low numbers of M. bovis
were contained in one part of the IMS sample and not the other;
and (d) both solid (Lowenstein-Jensen and Stonebrink slopes) and
liquid culture media were used during culture (and hence chances
of isolating viable M. bovis cells may have been higher), whereas
only liquid MGIT medium was inoculated after IMS. It is
estimated that approximately 0.5 to 2 g was inoculated into MGIT
tubes and from 80 mg to 1 g (depending on VL or NVL status)
onto slopes of solid culture media during culture, whereas
22.23 mg were used for IMS-MGIT culture, 11.11 mg in an
IMS-PCR reaction and 3.35 mg in a Direct PCR reaction. The
portion tested by culture may simply have contained more M. bovis
cells. It subsequently transpired that the sample after IMS had
been split into three portions unnecessarily, since IMS-spoligotyp-
ing did not prove possible. If IMS samples had been split into two
sub-samples (for IMS-PCR and IMS-MGIT culture only) de-
tection sensitivity of these two methods would have increased
proportionately.
Surprisingly, results for Direct PCR and IMS-PCR were only in
agreement (i.e. samples were positive or negative by both tests) for
55% of lymph node samples tested. Eighty-nine (31.78%) of 280
lymph node samples tested positive by both PCR methods, but
overall a higher percentage of lymph node samples tested positive
by IMS-PCR (162/280, 57.86%) than by direct PCR (141/280,
50.36%) (Figure 2). The results of the two PCR methods were only
significantly associated when results for the different lymph node
types were considered separately (McNemar’s Chi square test, VL
p= 0.032 or NVL p= 0.000, Table 1) but not when VL and NVL
results were combined (p = 0.076, Table 1). It must be re-
membered that the IS6110 PCR target is not confined to M. bovis
but to MTB complex mycobacteria more generally, so a Direct
PCR positive result may not necessarily indicate the presence of
M. bovis exclusively; although isolation of MTB complex species
other than M. bovis from cattle in Northern Ireland has been an
extremely rare occurrence. In contrast, a PCR positive result after
IMS probably does indicate the presence of only M. bovis, because
of the previously demonstrated specificity of the IMS part of the
test [5]. The presence of M. bovis DNA in tissue homogenates
which would be detected by Direct PCR, but not IMS-PCR, and
Figure 4. Distribution of M. bovis spoligotypes isolated by culture and IMS-MGIT culture. Spoligotypes 269 (140*), 142* and 263* are
thought to be spoligotypes 140, 142 and 263 with spacer 15 signal absent which have arisen due to lesser amounts of M. bovis DNA being present in
IMS-MGIT cultures.
doi:10.1371/journal.pone.0058374.g004
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the fact that IS6110 homologs from non-MTB complex bacteria
have previously been reported [12,13], are also possible explana-
tions for difference between Direct PCR and IMS-PCR findings.
Estimates of the detection sensitivity and specificity of the
alternative detection methods relative to culture (the gold standard
method [4], although acknowledged as imperfect) for each lymph
node type were calculated. Test specificity is regarded as the
probability than an uninfected animal will test negative, while test
sensitivity is defined as the probability that a truly infected animal
will test positive [16]. When NVL lymph nodes were tested the
sensitivity of both Direct PCR and IMS-PCR was 100% (95% CI:
15.81–100.0%) and specificities were 55.56% (95% CI: 43.38–
67.29%) and 56.94% (95% CI: 46.13–69.81%), respectively.
When VL lymph nodes were tested, the sensitivities of Direct PCR
and IMS-PCR were 50.00% (95% CI: 42.31–57.69%) and
62.21% (95% CI: 54.46–69.49%), respectively, and the specifi-
cities were lower at 38.24% (95% CI: 22.17–56.41%) and 35.29%
(95% CI: 19.74–53.53%), respectively. However, as culture is
considered the reference method for statistical analysis, the
consequence of extra test positives with IMS-PCR and Direct
PCR relative to culture is that these calculated values for specificity
are lower than they would actually be in reality [18]. This finding
of greater detection sensitivity and specificity with IMS-PCR
compared to direct PCR is consistent with those of previous studies
evaluating the impact of IMS before PCR on detection of M. bovis
in tissue or environmental samples [19,20,21].
Comparison of results of all detection methods
The performance of all alternative test methods relative to
culture was assessed by statistical analysis using McNemar’s Chi-
Square test to analyse 262 contingency tables. The outcomes for
all 280 lymph node samples, irrespective of lymph node type, are
summarised in Table 2. Results for the IMS-based methods
(except IMS-MGIT culture checked by ZN staining at end of
incubation period) were not significantly associated with culture
results (McNemar’s Chi-square test, p = 0.311 for IMS-PCR and
p= 0.106 for IMS-MGIT culture confirmed by IS6110 PCR at
end of incubation period), whereas Direct PCR and IMS-MGIT
culture confirmed by ZN staining at end of incubation period were
significantly associated (McNemar’s Chi-square test, p = 0.007 and
p= 0.000, respectively).
Test results were also subjected to generalised linear mixed
model analysis (GLMM) to determine the probability of a positive
detection of M. bovis by each test, and to assess if the type of lymph
node tested (VL v NVL) influenced the test outcome. GLMM
analysis indicated that there was a significant effect of lymph node
type per se (p,0.001) on probability of a positive test outcome,
which is not really surprising given that VL samples are likely to
contain higher numbers of M. bovis cells than NVL samples and so
less detection sensitivity would be required of a testing method to
achieve a positive result. GLMM analysis also indicated a signif-
icant interaction between lymph node type and test outcome
(p,0.001) in terms of M. bovis detection, so each test method did
not have the same probability of yielding a positive result for the
two sample types. For this reason, probabilities of M. bovis
detection by each test are presented separately for VL and NVL
lymph nodes samples in Figure 3. It was clear from these results
that in the case of NVL tissues three of the alternative detection
methods (Direct PCR, IMS-PCR and IMS-MGIT culture (with
PCR and spoligotyping confirmation)) had higher probabilities
(45.94%, 44.59% and 54.14%, respectively) of detecting presence
of M. bovis than culture (2.63%). In contrast, for VL lymph node
testing the highest probability of a positive test result was obtained
with culture (83.83%) and IMS-MGIT culture (with PCR and
spoligotyping confirmation of the presence of M. bovis) was best of
alternative tests (73.13%).
On the basis of the culture results obtained during this study,
our assessment is that the current culture protocol is deficient in
two areas. Firstly, oxalic acid treatment is employed to de-
contaminate the lymph node sample in order to inactivate non-
mycobacterial contaminants before culture, despite the knowledge
that some inactivation of M. bovis cells will occur. Use of
a detergent, alkali or acid treatment for decontamination of
lymph node tissue for M. bovis isolation is the prescribed method
[4], so use of oxalic acid is not unique to bTB testing in Northern
Ireland. However, the impact of its use is that M. bovis cells present
in NVL lymph nodes in low numbers are not being detected
routinely by culture, which undoubtedly has implications for the
confirmation of M. bovis in tissue samples. Secondly, ZN staining is
routinely used to confirm the presence of, typical acid-fast cells in
MGIT culture positive samples before spoligotyping; PCR
confirmation of the presence/absence of M. bovis DNA in MGIT
cultures is not currently undertaken. This study showed that
confirmation of the presence of M. bovis in IMS-MGIT cultures by
ZN staining is a very insensitive method; sensitivities of 0.00% for
NVL and 34.3% for VL samples relative to culture results.
However, both ZN staining and PCR testing of IMS-MGIT
cultures was performed, and results clearly indicate that a signif-
icant number of M. bovis positive MGIT cultures would have been
reported as negative solely on the basis of ZN staining, when in
reality low numbers of slowly growing, resuscitating M. bovis cells
may be present.
Spoligotyping
The potential to apply spoligotyping directly after immuno-
magnetic capture of M. bovis from lymph node material was
investigated because if it were possible this would allow earlier
confirmation of the presence of M. bovis infection in lymph nodes.
In preliminary trials on a range of dilutions ofM. bovis AF2122/96,
a full spoligotype profile was only obtained after IMS and
Zymoclean concentration when $56103 CFU/ml were present
before IMS; partial or no spoligotype profiles were obtained
otherwise. When a 100 ml aliquot of beads from a selection of
IMS-PCR positive lymph node samples was subjected to
spoligotyping, full spoligotype profiles were never obtained. The
spoligotyping protocol was originally optimised for DNA from M.
bovis cultures [15], which would contain a much higher quantity of
cells, and hence DNA, than obtained from cells captured from
lymph nodes by IMS. Therefore, spoligotyping directly after IMS
was not considered to be a feasible method for quickly
demonstrating the presence of M. bovis in a lymph node sample.
Spoligotyping was used in the usual manner to confirm the
isolation of M. bovis by testing slope or MGIT cultures. The
presence of M. bovis was confirmed in all 174 positive cultures and
in 107 of 190 positive IMS-MGIT (PCR) cultures by spoligotyp-
ing. The remaining 83 IMS-MGIT (PCR) positive cultures were
not subjected to spoligotyping because the earlier experiments had
indicated that high numbers of M. bovis were needed to yield
sufficient DNA to ensure successful spoligotyping, and for these
IMS-MGIT culture samples the PCR positive results generally
indicated the presence of low numbers of M. bovis/low levels of M.
bovis DNA. The distribution of spoligotypes obtained for cultures
and IMS-MGIT cultures is shown in Figure 4. The range of
different M. bovis spoligotypes isolated by the IMS-MGIT culture
method was not appreciably different from the range isolated by
culture, which was reassuring considering that the antibody and
peptide on the magnetic beads were generated using a single M.
bovis spoligotype (SB140). However, a consistent observation for
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many of the spoligotypes obtained from IMS-MGIT cultures was
the absence of a signal indicating spacer 15, meaning that
spoligotypes that were probably a recognised spoligotype (SB140,
SB142 or SB263) were reported as SB269, SB142* and SB263*,
respectively. Interestingly, in the case of the spoligotypes from
IMS-MGIT cultures, if the number of spacer 15-containing and
corresponding spacer 15-deficient cultures is combined (i.e.
SB140+ SB269, SB142+ SB142* and SB263+ SB263*) then the
percentages of each spoligotype for IMS-MGIT cultures almost
matches percentages for SB140, SB142 and SB263 spoligotypes
for cultures and both would then be consistent with reported M.
bovis spoligotype distributions in Northern Ireland cattle [22].
Therefore, this suggests that the spoligotyping results obtained are
probably due to borderline amounts of M. bovis DNA being
extracted from the IMS-MGIT cultures. The influence of DNA
quantity on spoligotype obtained has been demonstrated for M.
bovis AF2122/97 in the course of this study (when DNA was
extracted from a sample containing ,56103 cells/ml, spoligotype
SB269 was reported instead of 140, due to lack of signal
corresponding to spacer 15) but merits confirmation with M. bovis
spoligotypes SB142 and SB263, and perhaps other spoligotypes
also.
Conclusions
In this study there is evidence of higher M. bovis detection rates
using the IMS-based methods (IMS-PCR and IMS-MGIT culture)
compared to conventional culture, notably with bTB skin test
reactor animals presenting with non-visible lesions. Significantly,
using IMS-based methods, viable M. bovis cells were recovered
from NVL lymph node samples taken from skin test positive
animals, demonstrating M. bovis when culture methods failed to do
so. Using IMS to retrieve M. bovis from tissues circumvents the
need to decontaminate prior to culture and it is likely that this has
a positive impact on cell viability and hence improved recovery
rates from clinical samples.
There is potential to improve detection of M. bovis from clinical
specimens using IMS as a novel first step in sample preparation.
This method introduces a high degree of specificity for M. bovis by
selecting cells in apparently different physiological states (viable
and non-viable). The range of M. bovis spoligotypes isolated by the
IMS-MGIT culture method was very similar to the range isolated
by culture, implying that IMS can select a very broad range of
spoligotypes.
Confirmation of M. bovis in clinical samples can be streamlined
through the preparation of a single IMS treated sample which is
then split into two aliquots. PCR would be applied to the first
aliquot to rapidly detect M. bovis infected tissues within 24–
48 hours. MGIT culture would be applied to the second aliquot
and after 8 weeks incubation all cultures would be subjected to
PCR (targeting IS6110 or other suitable target) to confirm the
presence of viable M. bovis. Increased detection sensitivity by the
use of PCR to confirm the presence of M. bovis in MGIT cultures
compared with ZN staining was indicated by this study.
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